Japan court rejects race-specific antidepressant patent bid
Japan’s IP High Court has upheld the rejection of a patent application for a two-drug antidepressant treatment specifically for patients of Asian ancestry, finding that the claimed benefits were predictable from...To view the full article, register now.
Already a subscriber? Click here to view full article